Sage Therapeutics, Inc.

NASDAQ: SAGE
$41.76
-$1.61 (-3.7%)
Closing price August 3, 2021
Wednesday's top analyst upgrades and downgrades included AbbVie, Alcoa, Anheuser Busch, Applied Materials, CyberArk, Fox, Merck, Paychex, ViacomCBS and Waste Management.
Friday's top analyst upgrades and downgrades included AIG, Best Buy, Carvana, Dell Technologies, HP, L Brands, Monster Beverage, Twitter and Zscaler.
24/7 Wall St. looks at some big analyst calls that we have seen so far on Thursday, including AT&T, Expedia, Mattel and Urban Outfitters.
Tuesday's top analyst upgrades and downgrades included Avaya, Dell Technologies, On Semiconductor, Neurocrine Biosciences, Palo Alto Networks, Ping Identity, Poshmark and Switch.
Friday's top analyst upgrades and downgrades included Adobe, Ford, Goldman Sachs, Intel, Microsoft, Salesforce.com, Seagate Technology, Snowflake, Targa Resources and Walt Disney.
Friday's top analyst upgrades and downgrades included Ally Financial, Boeing, Cracker Barrel Old Country Store, Dish Network, FedEx, Marvell Technology, Prudential, Stitch Fix and Teladoc Health.
Canaccord Genuity recently released a report detailing some of the biggest biotech catalysts coming out over these next six months.
Wednesday's top analyst upgrades, downgrades and initiations included American Express, Boeing, Caterpillar, Lennar, Simon Property, Sirius XM, Six Flags, Tesla, Walmart and Zynga.
Sage Therapeutics shareholders took a bath on Thursday after results from its late-stage major depressive disorder trial came public.
Friday's top analyst upgrades and downgrades included Anthem, Ciena, Dollar General, Encana, Lennar, Lululemon Athletica, Sage Therapeutics, Target, Tesla, Trade Desk and Yext.
Thursday was a breakout day for a few biotech companies. Some made absolutely massive runs, while others fell off a cliff.